WORCESTER, Mass., Dec. 11, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM:GNBT - News) (http://www.generex.com) announced today that further results from its clinical trial of a novel immunotherapeutic cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc., will be presented at the 31st annual San Antonio Breast Cancer Symposium (http://www.sabcs.org, December 11-14). The new findings will be presented by COL George Peoples, MD, a collaborator of Antigen Express who has been directing the trials at the Brooke Army Medical Center.
